Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells.

Lukiw WJ, Cui JG, Yuan LY, Bhattacharjee PS, Corkern M, Clement C, Kammerman EM, Ball MJ, Zhao Y, Sullivan PM, Hill JM.

Neuroreport. 2010 Oct 6;21(14):922-7. doi: 10.1097/WNR.0b013e32833da51a.

PMID:
20683212
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Herpes simplex virus resistance to acyclovir: clinical relevance.

Pottage JC Jr, Kessler HA.

Infect Agents Dis. 1995 Sep;4(3):115-24. Review.

PMID:
8548189
[PubMed - indexed for MEDLINE]
3.

Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.

Piret J, Boivin G.

Antimicrob Agents Chemother. 2011 Feb;55(2):459-72. doi: 10.1128/AAC.00615-10. Epub 2010 Nov 15. Review.

PMID:
21078929
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Herpes simplex encephalitis : from virus to therapy.

Rozenberg F, Deback C, Agut H.

Infect Disord Drug Targets. 2011 Jun;11(3):235-50. Review.

PMID:
21488834
[PubMed - indexed for MEDLINE]
5.

Novel targets for the development of anti-herpes compounds.

Greco A, Diaz JJ, Thouvenot D, Morfin F.

Infect Disord Drug Targets. 2007 Mar;7(1):11-8. Review.

PMID:
17346207
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk